These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
201 related articles for article (PubMed ID: 31325180)
1. Low Levels of Alcohol Consumption, Obesity, and Development of Fatty Liver With and Without Evidence of Advanced Fibrosis. Chang Y; Ryu S; Kim Y; Cho YK; Sung E; Kim HN; Ahn J; Jung HS; Yun KE; Kim S; Sung KC; Sohn CI; Shin H; Wild SH; Byrne CD Hepatology; 2020 Mar; 71(3):861-873. PubMed ID: 31325180 [TBL] [Abstract][Full Text] [Related]
2. Nonheavy Drinking and Worsening of Noninvasive Fibrosis Markers in Nonalcoholic Fatty Liver Disease: A Cohort Study. Chang Y; Cho YK; Kim Y; Sung E; Ahn J; Jung HS; Yun KE; Shin H; Ryu S Hepatology; 2019 Jan; 69(1):64-75. PubMed ID: 30019340 [TBL] [Abstract][Full Text] [Related]
3. Depression and increased risk of non-alcoholic fatty liver disease in individuals with obesity. Cho IY; Chang Y; Sung E; Kang JH; Wild SH; Byrne CD; Shin H; Ryu S Epidemiol Psychiatr Sci; 2021 Mar; 30():e23. PubMed ID: 33706839 [TBL] [Abstract][Full Text] [Related]
4. Interaction Between Alcohol Consumption Patterns, Antiretroviral Therapy Type, and Liver Fibrosis in Persons Living with HIV. Bilal U; Lau B; Lazo M; McCaul ME; Hutton HE; Sulkowski MS; Moore RD; Chander G AIDS Patient Care STDS; 2016 May; 30(5):200-7. PubMed ID: 27158847 [TBL] [Abstract][Full Text] [Related]
5. A Cohort Study Examining the Interaction of Alcohol Consumption and Obesity in Hepatic Steatosis and Mortality. Peeraphatdit TB; Ahn JC; Choi DH; Allen AM; Simonetto DA; Kamath PS; Shah VH Mayo Clin Proc; 2020 Dec; 95(12):2612-2620. PubMed ID: 33276835 [TBL] [Abstract][Full Text] [Related]
6. Sleep Duration, Sleep Quality, and the Development of Nonalcoholic Fatty Liver Disease: A Cohort Study. Um YJ; Chang Y; Jung HS; Cho IY; Shin JH; Shin H; Wild SH; Byrne CD; Ryu S Clin Transl Gastroenterol; 2021 Oct; 12(10):e00417. PubMed ID: 34665792 [TBL] [Abstract][Full Text] [Related]
7. Prediction of future hepatocellular carcinoma incidence in moderate to heavy alcohol drinkers with the FIB-4 liver fibrosis index. Suh B; Yun JM; Park S; Shin DW; Lee TH; Yang HK; Ahn E; Lee H; Park JH; Cho B Cancer; 2015 Nov; 121(21):3818-25. PubMed ID: 26178294 [TBL] [Abstract][Full Text] [Related]
8. Hepatic steatosis progresses faster in HIV mono-infected than HIV/HCV co-infected patients and is associated with liver fibrosis. Pembroke T; Deschenes M; Lebouché B; Benmassaoud A; Sewitch M; Ghali P; Wong P; Halme A; Vuille-Lessard E; Pexos C; Klein MB; Sebastiani G J Hepatol; 2017 Oct; 67(4):801-808. PubMed ID: 28527666 [TBL] [Abstract][Full Text] [Related]
9. Obesity and harmful alcohol consumption are predictors for advanced liver disease in the disease management program for type 2 diabetes. Michel M; Doll M; Albert N; Morgenstern M; Behr A; Maxeiner S; Labenz C; Galle PR; Schattenberg JM United European Gastroenterol J; 2024 Feb; 12(1):11-21. PubMed ID: 38206118 [TBL] [Abstract][Full Text] [Related]
10. Low heart rate variability from 10-s electrocardiograms is associated with development of non-alcoholic fatty liver disease. Choi IY; Chang Y; Kang G; Jung HS; Shin H; Wild SH; Byrne CD; Ryu S Sci Rep; 2022 Jan; 12(1):1062. PubMed ID: 35058515 [TBL] [Abstract][Full Text] [Related]
11. Physical activity and risk of fatty liver in people with different levels of alcohol consumption: a prospective cohort study. Tsunoda K; Kai Y; Uchida K; Kuchiki T; Nagamatsu T BMJ Open; 2014 Aug; 4(8):e005824. PubMed ID: 25095878 [TBL] [Abstract][Full Text] [Related]
12. The combined effects of alcohol consumption and body mass index on hepatic steatosis in a general population sample of European men and women. Lau K; Baumeister SE; Lieb W; Meffert PJ; Lerch MM; Mayerle J; Völzke H Aliment Pharmacol Ther; 2015 Mar; 41(5):467-76. PubMed ID: 25588768 [TBL] [Abstract][Full Text] [Related]
13. Alcohol drinking patterns and the risk of fatty liver in Japanese men. Hiramine Y; Imamura Y; Uto H; Koriyama C; Horiuchi M; Oketani M; Hosoyamada K; Kusano K; Ido A; Tsubouchi H J Gastroenterol; 2011 Apr; 46(4):519-28. PubMed ID: 20967556 [TBL] [Abstract][Full Text] [Related]
14. Decrease in Sleep Duration and Poor Sleep Quality over Time Is Associated with an Increased Risk of Incident Non-Alcoholic Fatty Liver Disease. Um YJ; Chang Y; Jung HS; Cho IY; Shin JH; Shin H; Wild SH; Byrne CD; Ryu S J Pers Med; 2022 Jan; 12(1):. PubMed ID: 35055407 [TBL] [Abstract][Full Text] [Related]
15. Analysis of alcohol use, consumption of micronutrient and macronutrients, and liver health in the 2017-2018 National Health and Nutrition Examination Survey. Warner JB; Zirnheld KH; Hu H; Floyd A; Kong M; McClain CJ; Kirpich IA Alcohol Clin Exp Res; 2022 Nov; 46(11):2025-2040. PubMed ID: 36124871 [TBL] [Abstract][Full Text] [Related]
16. Prevalence of non-alcoholic fatty liver disease and advanced fibrosis in Hong Kong Chinese: a population study using proton-magnetic resonance spectroscopy and transient elastography. Wong VW; Chu WC; Wong GL; Chan RS; Chim AM; Ong A; Yeung DK; Yiu KK; Chu SH; Woo J; Chan FK; Chan HL Gut; 2012 Mar; 61(3):409-15. PubMed ID: 21846782 [TBL] [Abstract][Full Text] [Related]
17. Ethnicity matters: A Systematic Review and Meta-Analysis of the Non-Linear Relationship Between Alcohol Consumption and Prevalence and Incidence of Hepatic Steatosis. Roerecke M; Nanau R; Rehm J; Neuman M EBioMedicine; 2016 Jun; 8():317-330. PubMed ID: 27428441 [TBL] [Abstract][Full Text] [Related]
18. Impact of Obesity and Alanine Aminotransferase Levels on the Diagnostic Accuracy for Advanced Liver Fibrosis of Noninvasive Tools in Patients With Nonalcoholic Fatty Liver Disease. Petta S; Wai-Sun Wong V; Bugianesi E; Fracanzani AL; Cammà C; Hiriart JB; Lai-Hung Wong G; Vergniol J; Wing-Hung Chan A; Giannetti A; Merrouche W; Lik-Yuen Chan H; Le-Bail B; Lombardi R; Guastella S; Craxì A; de Ledinghen V Am J Gastroenterol; 2019 Jun; 114(6):916-928. PubMed ID: 31169533 [TBL] [Abstract][Full Text] [Related]
19. Biphasic effect of alcohol intake on the development of fatty liver disease. Takahashi H; Ono M; Hyogo H; Tsuji C; Kitajima Y; Ono N; Eguchi T; Fujimoto K; Chayama K; Saibara T; Anzai K; Eguchi Y J Gastroenterol; 2015 Nov; 50(11):1114-23. PubMed ID: 25733100 [TBL] [Abstract][Full Text] [Related]